Related Experiment Video

Updated: Nov 21, 2025

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

7.6K

Achieving effective and selective CK1 inhibitors through structure modification

Chenxi Du1, Hongyu Yang1, Feng Feng2,3

  • 1Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, People's Republic of China.

Future Medicinal Chemistry
|January 13, 2021
PubMed

Insights

Developing selective Casein kinase 1 (CK1) inhibitors is challenging due to isoform similarity. This study reviews existing CK1 inhibitors to guide future structure-based drug design for improved efficacy and selectivity.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Casein kinase 1 (CK1) is a serine/threonine kinase family with six human isoforms.
  • CK1 plays a role in numerous biological processes, making it a therapeutic target for diseases like cancer, inflammation, and neurodegenerative disorders.
  • The structural similarity among CK1 isoforms complicates the development of selective inhibitors.

Purpose of the Study:

  • To analyze existing Casein kinase 1 (CK1) inhibitors.
  • To provide insights for structure-based drug design of novel CK1 inhibitors.
  • To guide rational structure modification for enhanced inhibitor efficacy and selectivity.

Main Methods:

  • Review and analysis of published CK1 inhibitor structures and their design strategies.
  • Examination of structure-activity relationships for known CK1 inhibitors.
  • Comparative analysis of inhibitor selectivity across CK1 isoforms.

Main Results:

  • Several CK1 inhibitors offer valuable lessons for drug design.
  • Structure-based approaches have yielded insights into achieving selectivity.
  • Modification strategies can improve inhibitor effectiveness.

Conclusions:

  • Further research into structure-based drug design is crucial for developing effective and selective CK1 inhibitors.
  • Lessons learned from current inhibitors can accelerate the discovery of new therapeutic agents.
  • Targeting CK1 remains a promising avenue for treating various pathological conditions.
Keywords:
Wnt signalingcancercasein kinase 1selective kinase inhibitorsstructure modificationstructure-based drug design

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.6K
A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.4K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
88.9K
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
88.7K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K